Screening Study for Heart Failure With Preserved Ejection Fraction in Adults Aged 50 to 89 in the Capital Region of Denmark

What this Trial Is About

Heart failure with preserved ejection fraction HFpEF is becoming the most common form of heart failure worldwide, especially among older adults and those with conditions like obesity, diabetes, and hypertension. HFpEF is linked to high rates of illness, death, and hospitalizations, posing a major health challenge. Despite its prevalence, HFpEF often goes undiagnosed, highlighting the need for better identification and management strategies. This study is a prospective, observational cohort design that uses Danish National Health Registries to identify up to 5000 individuals aged 50 to 89 living in the Capital Region of Denmark who have risk factors for HFpEF. Recruitment is conducted by sending invitation letters through a secure electronic mailbox linked to participants social security numbers. The study focuses on evaluating the screening and identification processes for HFpEF and understanding participants willingness to join the study. Participants will be monitored from the invitation date for about 12 months to assess the screening procedures. Researchers will measure how many eligible adults agree to participate and identify any barriers to involvement. The study will also analyze data until March 2026 to help improve future efforts in finding and enrolling patients with HFpEF, especially those who are vulnerable.

Copenhagen Heart Failure With Preserved Ejection Fraction